Therapeutic inhibitors of PAI-1 function and methods of their use

The invention relates to mammalian PAI-I ligands and modulators. In particular, the invention relates to polypeptides, polypeptide compositions and polynucleotides that encode polypeptides that are ligands and/or modulators of PAI-I. The invention also relates to polyligands that are homopolyligands...

Full description

Saved in:
Bibliographic Details
Main Authors REED, THOMAS D, REED, CHARLES C, MERENICK, BETHANY L, MAZZARELLI SOPCZYNSKI, JOAN, TASHEVA, ELENA, CARSON, JONATHAN, PETERSON, RICHARD E, BAIR, CATHERINE L
Format Patent
LanguageEnglish
Published 04.12.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to mammalian PAI-I ligands and modulators. In particular, the invention relates to polypeptides, polypeptide compositions and polynucleotides that encode polypeptides that are ligands and/or modulators of PAI-I. The invention also relates to polyligands that are homopolyligands or heteropolyligands that modulate PAI-I activity. The invention also relates to ligands and polyligands localized to a region of a cell. The invention also relates to localization tethers and promoter sequences that can be used to provide spatial control of the PAI-I ligands and polyligands. The invention also relates to inducible gene switches that can be used to provide temporal control of the PAI-I ligands and polyligands. The invention also relates to methods of treating or preventing atherosclerosis. The invention also relates to methods of treating or preventing fibrosis.
Bibliography:Application Number: AU20090204464